Recently, we demonstrated that parecoxib and 5-fluorouracil synergistically reduce the epithelial to mesenchymal transition and subsequent metastasis in colorectal cancer through targeting PI3K/Akt/NF-κB signaling [28]. This evidence concerns the gene AKT1 and colorectal cancer.